GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2026

Conditions
Major Neurocognitive Disorder
Interventions
OTHER

GPS clinical intervention

Nurses and doctors in exposed FMGs and home care teams (HCTs) will be asked to refer to the FMG pharmacist all seniors undergoing cognitive evaluation OR referred to a memory clinic OR recently diagnosed with a cognitive disorder, for a complete and critical review of their medication therapy. FMG pharmacists will be asked to conduct an interview with each referred senior and his or her caregiver, if applicable, in order to establish the best possible treatment regimen. They will compare the information collected with another reliable data source (e.g., pharmacy records) in order to perform medication reconciliation and will then evaluate the medication related problems. Pharmacist will establish a care plan and the follow-ups to be carried out with the patient in collaboration with the health care team. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.

Trial Locations (2)

H3M 2X6

RECRUITING

GMF Bordeaux-Cartierville, Montreal

G5Y 5L6

RECRUITING

GMF Abénakis, Saint-Georges

All Listed Sponsors
collaborator

CISSS de Chaudière-Appalaches

OTHER_GOV

collaborator

Ciusss de L'Est de l'Île de Montréal

OTHER

collaborator

Fonds de la Recherche en Santé du Québec

OTHER_GOV

lead

CHU de Quebec-Universite Laval

OTHER